Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ambrosia: Evaluating the Effects of a Food-As-Medicine Platform on Gut Microbiome Composition and Metabolism

NCT06091813 is registered in ClinicalTrials.gov with Persephone Biosciences as lead sponsor.

NCT NCT06091813
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06091813 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ambrosia: Evaluating the Effects of a Food-As-Medicine Platform on Gut Microbiome Composition and Metabolism
Lead sponsor
Persephone Biosciences
Phase
Not applicable
Overall status
Completed
Start date
November 1, 2023
Completion date
March 15, 2025
Enrollment
546 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

impact of dietary chages directed by medical nutrition therapy on gut microbiome composition